US 9,844,560 B2Granted

Use of ginsenoside M1 for treating lupus nephritis

AssigneeSheau-Long Lee

InventorsSheau-Long Lee, Yu-Chieh Lee, Ann Chen, Kuo-Feng Hua, Shuk-Man Ka

Life of this patent

Estimating the term…

Abstract

The present invention provides a method of treating a subject afflicted with lupus nephritis comprising administering to the subject an amount of ginsenoside M1 effective to treat the subject.

Claims5

Dependent claims

A method of treating lupus nephritis comprising administering a therapeutically effective amount of ginsenoside M1 to a subject in need.

Dependencies are inferred from the claim text.

Facts

Application: 15/308,069Filed 4 May 2015 · us provisional application
Priority: 2 May 2014
Published: US 2017/0049792 A123 Feb 2017
Granted: 19 Dec 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 31/704
Attached to a carbocyclic compound, e.g. phloridzin: attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin,…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 13/12
Drugs for disorders of the urinary system: of the kidneys
A61P 37/00
Drugs for immunological or allergic disorders

Family

Application61/987,631Us provisional application · filed 2 May 2014
US 2017/0049792 A1Pre-grant publication · published 23 Feb 2017
US 9,844,560 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results